Amphastar Pharmaceuticals Other Long Term Liabilities (Quarterly) Analysis

Amphastar Pharmaceuticals, Inc. (AMPH)

27.75 -1.16 (-4.01%) USD | NASDAQ | Jan 14, 16:00

27.75 0.00 (0.00%) After-Hours: 18:11

View Other Long Term Liabilities (Quarterly) for AMPH.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	Upgrade
Supernus Pharmaceuticals, Inc.	Upgrade
Catalyst Pharmaceuticals, Inc.	Upgrade
Pfizer Inc.	Upgrade
CorMedix, Inc.	--